Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01090323
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 185
Large-scale testing (Phase 3)Study completedNCT00152490
What this trial is testing

Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Who this might be right for
Crohn's Disease
UCB Pharma 604
Not applicableStudy completedNCT04388241
What this trial is testing

Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD

Who this might be right for
Sickle Cell DiseasePain
Children's National Research Institute 22
Not applicableStudy completedNCT06880679
What this trial is testing

Ultrasound Acute Chest Syndrome Sickle Cell Disease

Who this might be right for
Acute Chest SyndromeSickle Cell Disease
Indiana University 27
Early research (Phase 1)Looking for participantsNCT07566494
What this trial is testing

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Who this might be right for
Sickle Cell Disease, Hemolytic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 25
Post-approval studies (Phase 4)Study completedNCT02522104
What this trial is testing

Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

Who this might be right for
Sickle Cell DiseaseRenal Function Disorder
Theravia 40
Not applicableLooking for participantsNCT03327428
What this trial is testing

Sickle-cell Disease Registry of the GPOH

Who this might be right for
Sickle Cell Disease
University Hospital Heidelberg 1,000
Not applicableUnknownNCT00327639
What this trial is testing

Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto

Who this might be right for
ThalassemiaFertilityPregnancy
University Health Network, Toronto 50
Not applicableStudy completedNCT01496963
What this trial is testing

Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

Who this might be right for
Thalassemia MajorThalassemia IntermediaPulmonary Arterial Hypertension
Ente Ospedaliero Ospedali Galliera 1,500
Not applicableStudy completedNCT03591900
What this trial is testing

The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients

Who this might be right for
DiabetesPrediabetesB-Thalassemia
Ain Shams University 200
Not applicableStudy completedNCT02855957
What this trial is testing

Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes

Who this might be right for
Thalassemic Syndromes
Assistance Publique - Hôpitaux de Paris 135
Not applicableLooking for participantsNCT06298630
What this trial is testing

Long-term Follow-up Study of BRL-101 for TDT

Who this might be right for
Thalassemia, Beta
Bioray Laboratories 45
Testing effectiveness (Phase 2)Looking for participantsNCT05519111
What this trial is testing

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Who this might be right for
Sickle Cell Disease
Icahn School of Medicine at Mount Sinai 60
Testing effectiveness (Phase 2)Study completedNCT04053764
What this trial is testing

Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 58
Not applicableNot Yet RecruitingNCT07502781
What this trial is testing

Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants

Who this might be right for
Extremely Premature InfantAnemia NeonatalBlood Transfusion+6 more
Hospital Clinic of Barcelona 176
Testing effectiveness (Phase 2)Study completedNCT05098028
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Bausch Health Americas, Inc. 44
Not applicableEnded earlyNCT02445144
What this trial is testing

Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
Albert Einstein College of Medicine 26
Testing effectiveness (Phase 2)Study completedNCT02125877
What this trial is testing

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Who this might be right for
Chronic Iron Overload Due to Transfusion-dependant Anemias
Novartis Pharmaceuticals 173
Large-scale testing (Phase 3)Study completedNCT02906202
What this trial is testing

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 24
Not applicableUnknownNCT03101423
What this trial is testing

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Who this might be right for
Beta Thalassemia Major
First Affiliated Hospital of Guangxi Medical University 30
Next Page